A double-blinded, randomized, parallel intervention to evaluate biomarker-based nutrition plans for weight loss: The...

Area of Science:

• Metabolic health and precision nutrition.
• Obesity and weight management.

Background:

• Biomarker-guided dietary interventions show promise for optimizing treatment response.
• The PREVENTOMCIS platform uses metabolomic and genetic data for personalized dietary plans.

Purpose of the Study:

• To evaluate the efficacy of the PREVENTOMCIS platform for improving health outcomes in individuals with overweight or obesity.
• To compare a personalized diet with a control diet in a randomized intervention.

Main Methods:

• A 10-week, double-blinded, randomized intervention with 100 adults (BMI 27–40 kg/m²).
• Participants were assigned to a personalized diet or a control diet group.
• Primary outcome was change in fat mass measured by dual-energy X-ray absorptiometry.

Main Results:

• No significant difference in fat mass change between the personalized and control diet groups (–2.1 kg vs. –2.0 kg).
• Both groups showed significant improvements in insulin resistance and lipid profiles.
• No significant differences between groups for other measured endpoints like body weight, waist circumference, or inflammatory markers.

Conclusions:

• Personalized dietary plans did not demonstrate superior benefits over a generally healthy control diet in this 10-week trial.
• Further research is necessary to validate precision nutrition approaches for obesity management.
• Translating precision nutrition science into clinically applicable dietary advice is crucial for reducing obesity-related comorbidities.